De-risking Drug Development | Episode 1: How to drive value in pre-clinical development
De-risking Drug Development is a five-part podcast series that explores the business-critical decisions that take place at each stage of the drug development process. We know that novel therapies often don’t meet their revenue expectations, but through informed decision-making, you can minimize risk and maximize the probability of commercial success.
In episode one we discuss the critical decision points in the pre-clinical phase that can ultimately determine the success of your product. Specifically, we consider how biotech sponsors should translate the science to clinical application and communicate this effectively to investors. We also explore the other key stakeholder groups where strategic communication planning should start early, and we focus on how including the patient perspective in the pre-clinical phase can impact commercial success.
Episode 1: Determine how to drive value in pre-clinical development
Episode 2: Focus on safety and efficacy and prove quickly that your product works
Episode 3: Plan how to get to market quickly, post-proof of concept
Episode 4: Implement market launch strategy, pre-approval
Episode 5: Expand the use and value of your product over time
Related Insights
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
Enabling Successful Sites, Ep3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Article
Making rare disease drug development personal
Jan 8, 2021
Podcast
Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit
Sep 19, 2022
Blog
SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change
Aug 24, 2022
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
How we can bring gene therapies to bear on diseases of aging
Jan 31, 2024
Blog
How sponsors can make it easier for rare disease patients and families to participate in trials
Feb 13, 2024
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Podcast
Rare endpoints: Delivering on unmet patient needs
May 7, 2024
Related Insights
Podcast
Enabling Successful Sites, Ep2: Empowering Sites to be More Inclusive Through Cultural Sensitivity Training
Jun 28, 2024
Podcast
Enabling Successful Sites, Ep3: Taking the complexity out of oncology clinical trials
Jun 28, 2024
Article
Making rare disease drug development personal
Jan 8, 2021
Podcast
Driving change in Cell & Gene Therapies: Key learnings from the SITC Virtual Summit
Sep 19, 2022
Blog
SITC Crisis in Clinical Research Virtual Summit – Collaborating to Drive Change
Aug 24, 2022
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Blog
Parexel names first Patient Ambassador
Jun 17, 2022
Blog
How we can bring gene therapies to bear on diseases of aging
Jan 31, 2024
Blog
How sponsors can make it easier for rare disease patients and families to participate in trials
Feb 13, 2024
Video
Biotech Showcase: Fireside Chat with Jamie Macdonald
Jan 3, 2022
Blog
Studying multiple versions of a cellular or gene therapy product in an early-phase clinical trial
Nov 19, 2021
Podcast
Rare endpoints: Delivering on unmet patient needs
May 7, 2024